Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Optimal treatment and management of Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Hemophilia: Improve general knowledge level of gene therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Serotyping of Streptococcus pneumoniae
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Artificial Intelligence/Machine Learning Research in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan